Income Statement Decoy Therapeutics Inc. London S.E.

Stocks

US79400X6022

Biotechnology & Medical Research

End-of-day quote London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

08-12	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

7c8c32905579869da6b3f2.lcpqcSBTyhHljhF2PJPd8k4yhHbu5dDgOYu0O2Z3Bus.4JAhQm0ku2SE3msCbquSmntlxRGbk4q1WLn1CF82Z4TcoQcgVBuZe5SjKQ

Published financial data: DECOY THERAPEUTICS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	1.84M	-	-	-	-
Total Revenues	1.84M	-	-	-	-
Cost of Goods Sold, Total	8.55M	15.84M	-	-	-
Gross Profit	-6.71M	-15.84M	-	-	-
Selling General & Admin Expenses, Total	6.1M	7.14M	5.72M	4.96M	3.73M
R&D Expenses	-	-	7.17M	770K	368K
Other Operating Expenses, Total	6.1M	7.14M	12.89M	5.73M	4.1M
Operating Income	-12.81M	-22.98M	-12.89M	-5.73M	-4.1M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	-	219K	352K	159K	95.47K
Net Interest Expenses	-	219K	352K	159K	95.47K
Other Non Operating Income (Expenses)	44.69K	14.45K	-	-	-
EBT, Excl. Unusual Items	-12.77M	-22.74M	-12.54M	-5.58M	-4M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-8.87M	-	-	-
In Process R&D Expenses	-	-	-	-	-8.52M
EBT, Incl. Unusual Items	-12.77M	-31.61M	-12.54M	-5.58M	-12.52M
Earnings From Continuing Operations	-12.77M	-31.61M	-12.54M	-5.58M	-12.52M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-12.77M	-31.61M	-12.54M	-5.58M	-12.52M
Net Income - (IS)	-12.77M	-31.61M	-12.54M	-5.58M	-12.52M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-12.77M	-31.61M	-12.54M	-5.58M	-12.52M
Net Income to Common Excl. Extra Items	-12.77M	-31.61M	-12.54M	-5.58M	-12.52M
Per Share Items
Net EPS - Basic	-	-	-	-	-129.1
Basic EPS - Continuing Operations	-	-	-	-	-129.1
Basic Weighted Average Shares Outstanding	-	-	-	-	96.97K
Net EPS - Diluted	-	-	-	-	-129.1
Diluted EPS - Continuing Operations	-	-	-	-	-129.1
Diluted Weighted Average Shares Outstanding	-	-	-	-	96.97K
Normalized Basic EPS	-	-	-	-	-25.79
Normalized Diluted EPS	-	-	-	-	-25.79
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	-12.79M	-22.97M	-12.88M	-5.73M	-4.09M
EBITA	-12.81M	-22.98M	-12.89M	-5.73M	-4.1M
EBIT	-12.81M	-22.98M	-12.89M	-5.73M	-4.1M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	-	-	-	-	-
Normalized Net Income	-7.98M	-14.21M	-7.84M	-3.48M	-2.5M
Supplemental Operating Expense Items
General and Administrative Expenses	6.1M	7.14M	5.72M	4.96M	3.73M
Research And Development Expense From Footnotes	8.55M	15.84M	7.17M	770K	368K
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	559K	797K	525K	274K	219K
Total Stock-Based Compensation	559K	797K	525K	274K	219K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	29.21M	12.11M	5.9M	2.43M	10.71M
Total Cash And Short Term Investments	29.21M	12.11M	5.9M	2.43M	10.71M
Accounts Receivable, Total	-	1.61M	-	-	-
Total Receivables	-	1.61M	-	-	-
Prepaid Expenses	949K	803K	620K	331K	275K
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	-	-	222K	-
Total Current Assets	30.16M	14.52M	6.52M	2.99M	10.99M
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	7.88K	-	-	-	40.56K
Goodwill	8.87M	-	-	-	-
Other Intangibles, Total	-	-	-	-	-
Accounts Receivable Long-Term	1.61M	-	-	-	-
Other Long-Term Assets, Total	186K	131K	66.85K	35.41K	30.99K
Total Assets	40.83M	14.65M	6.59M	3.02M	11.06M
Liabilities
Accounts Payable, Total	1.54M	2.86M	603K	937K	941K
Accrued Expenses, Total	553K	1.41M	407K	352K	859K
Short-term Borrowings	-	-	290K	222K	-
Unearned Revenue Current, Total	-	-	-	-	3.23M
Other Current Liabilities	14.52K	-	-	-	142K
Total Current Liabilities	2.11M	4.27M	1.3M	1.51M	5.17M
Total Liabilities	2.11M	4.27M	1.3M	1.51M	5.17M
Preferred Stock Redeemable	-	-	-	-	-
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	4.52K	225	393	144	53
Additional Paid In Capital	70.92M	74.19M	81.63M	83.44M	100M
Retained Earnings	-32.2M	-63.81M	-76.35M	-81.92M	-94.44M
Total Common Equity	38.72M	10.38M	5.29M	1.51M	5.89M
Total Equity	38.72M	10.38M	5.29M	1.51M	5.89M
Total Liabilities And Equity	40.83M	14.65M	6.59M	3.02M	11.06M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.3K	-	-	-	532K
ECS Total Common Shares Outstanding	1.26K	-	-	-	532K
Book Value / Share	30.81K	-	-	-	11.07
Tangible Book Value	29.86M	10.38M	5.29M	1.51M	5.89M
Tangible Book Value Per Share	23.75K	-	-	-	11.07
Total Debt	0	0	290K	222K	0
Net Debt	-29.21M	-12.11M	-5.61M	-2.21M	-10.71M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	-	-	-
Full Time Employees	16	12	2	2	11
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-12.77M	-31.61M	-12.54M	-5.58M	-12.52M
Depreciation & Amortization - CF	19.18K	6.68K	10.05K	4.42K	7.15K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	19.18K	6.68K	10.05K	4.42K	7.15K
Asset Writedown & Restructuring Costs	-	10.85M	-	-	8.52M
Stock-Based Compensation (CF)	559K	797K	525K	274K	219K
Other Operating Activities, Total	-44.69K	-14.45K	130K	-	-6.54K
Change In Accounts Receivable	2.25M	-	1.48M	-	-
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	-311K	1.31M	-2.26M	334K	-1.17M
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	99.66K	1.06M	-193K	438K	121K
Cash from Operations	-10.2M	-17.6M	-12.85M	-4.53M	-4.83M
Capital Expenditure	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-1.5M	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-577K
Other Investing Activities, Total	-	-	-	-	1.34M
Cash from Investing	-	-1.5M	-	-	765K
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-477K	-	-281K	-467K	-222K
Total Debt Repaid	-477K	-	-281K	-467K	-222K
Issuance of Common Stock	28.77M	1.99M	6.92M	1.53M	12.56M
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	28.3M	1.99M	6.64M	1.06M	12.34M
Net Change in Cash	18.1M	-17.11M	-6.21M	-3.47M	8.28M
Supplemental Items
Cash Interest Paid	1.47K	-	14.75K	10.64K	5.8K
Levered Free Cash Flow	-3.89M	-14.37M	-8.99M	-2.96M	1.82M
Unlevered Free Cash Flow	-3.89M	-14.37M	-8.99M	-2.96M	1.82M
Change In Net Working Capital	-3.54M	-691K	1.46M	-347K	-4.16M
Net Debt Issued / Repaid	-477K	-	-281K	-467K	-222K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-24.35	-51.76	-75.9	-74.59	-36.36
Return on Total Capital	-26.1	-58.48	-100.98	-98.05	-67.17
Return On Equity %	-41.94	-128.73	-160.07	-164.02	-338.31
Return on Common Equity	-41.94	-128.73	-160.07	-164.02	-338.31
Margin Analysis
Gross Profit Margin %	-364.54	-	-	-	-
SG&A Margin	331.73	-	-	-	-
EBITDA Margin %	-695.23	-	-	-	-
EBITA Margin %	-696.27	-	-	-	-
EBIT Margin %	-696.27	-	-	-	-
Income From Continuing Operations Margin %	-693.84	-	-	-	-
Net Income Margin %	-693.84	-	-	-	-
Net Avail. For Common Margin %	-693.84	-	-	-	-
Normalized Net Income Margin	-433.65	-	-	-	-
Levered Free Cash Flow Margin	-211.18	-	-	-	-
Unlevered Free Cash Flow Margin	-211.18	-	-	-	-
Asset Turnover
Asset Turnover	0.06	-	-	-	-
Fixed Assets Turnover	120.6	-	-	-	-
Short Term Liquidity
Current Ratio	14.29	3.4	5.02	1.98	2.13
Quick Ratio	13.84	3.22	4.54	1.61	2.07
Operating Cash Flow to Current Liabilities	-4.83	-4.12	-9.89	-2.99	-0.93
Average Days Payable Outstanding	72.52	50.72	-	-	-
Long Term Solvency
Total Debt/Equity	-	-	5.48	14.68	-
Total Debt / Total Capital	-	-	5.19	12.8	-
Total Liabilities / Total Assets	5.17	29.12	19.73	49.99	46.74
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	-	-	-0.02	-0.04	-
Net Debt / EBITDA	2.28	0.53	0.44	0.39	2.62
Total Debt / (EBITDA - Capex)	-	-	-0.02	-0.04	-
Net Debt / (EBITDA - Capex)	2.28	0.53	0.44	0.39	2.62
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-64.84	-	-	-	-
Gross Profit, 1 Yr. Growth %	299.17	136.08	-	-	-
EBITDA, 1 Yr. Growth %	64.69	79.53	-43.9	-55.53	-28.64
EBITA, 1 Yr. Growth %	64.56	79.31	-43.87	-55.53	-28.57
EBIT, 1 Yr. Growth %	64.56	79.31	-43.87	-55.53	-28.57
Earnings From Cont. Operations, 1 Yr. Growth %	73.66	147.55	-60.32	-55.55	124.52
Net Income, 1 Yr. Growth %	73.66	147.55	-60.32	-55.55	124.52
Normalized Net Income, 1 Yr. Growth %	73.66	78.11	-44.85	-55.55	-28.25
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-	85.66
Net Property, Plant and Equip., 1 Yr. Growth %	-65.19	-	-	-	-
Total Assets, 1 Yr. Growth %	63.78	-64.12	-55.04	-54.1	265.76
Tangible Book Value, 1 Yr. Growth %	124.6	-65.22	-49.09	-71.41	289.56
Common Equity, 1 Yr. Growth %	74.75	-73.18	-49.09	-71.41	289.56
Cash From Operations, 1 Yr. Growth %	-1.08	72.5	-26.99	-64.77	6.67
Levered Free Cash Flow, 1 Yr. Growth %	-55.68	269.65	-37.44	-67.07	-161.58
Unlevered Free Cash Flow, 1 Yr. Growth %	-55.68	269.65	-37.44	-67.07	-161.58
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-27.12	-	-	-	-
Gross Profit, 2 Yr. CAGR %	248.01	206.98	-	-	-
EBITDA, 2 Yr. CAGR %	24.55	71.95	0.36	-50.05	-43.67
EBITA, 2 Yr. CAGR %	24.51	71.78	0.32	-50.04	-43.64
EBIT, 2 Yr. CAGR %	24.51	71.78	0.32	-50.04	-43.64
Earnings From Cont. Operations, 2 Yr. CAGR %	35.68	107.34	-0.89	-58	-0.1
Net Income, 2 Yr. CAGR %	35.68	107.34	-0.89	-58	-0.1
Normalized Net Income, 2 Yr. CAGR %	35.68	75.88	-0.89	-50.48	-43.52
Accounts Receivable, 2 Yr. CAGR %	-	-35.37	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-43.88	-	-	-	-
Total Assets, 2 Yr. CAGR %	71.43	-23.34	-59.84	-54.58	29.56
Tangible Book Value, 2 Yr. CAGR %	317.25	-11.61	-57.92	-61.85	5.54
Common Equity, 2 Yr. CAGR %	91.3	-31.54	-63.05	-61.85	5.54
Cash From Operations, 2 Yr. CAGR %	-6.15	30.63	12.22	-49.29	-38.7
Levered Free Cash Flow, 2 Yr. CAGR %	-6.06	27.99	52.07	-54.61	-54.97
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.06	27.99	52.07	-54.61	-54.97
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.94	-	-	-	-
Gross Profit, 3 Yr. CAGR %	116.21	205.78	-	-	-
EBITDA, 3 Yr. CAGR %	97.22	40.69	18.37	-23.49	-43.75
EBITA, 3 Yr. CAGR %	96.66	40.61	18.31	-23.51	-43.72
EBIT, 3 Yr. CAGR %	96.66	40.61	18.31	-23.51	-43.72
Earnings From Cont. Operations, 3 Yr. CAGR %	97.02	65.79	19.49	-24.13	-26.56
Net Income, 3 Yr. CAGR %	97.02	65.79	19.49	-24.13	-26.56
Normalized Net Income, 3 Yr. CAGR %	97.02	48.56	19.49	-24.13	-43.97
Net Property, Plant and Equip., 3 Yr. CAGR %	-40.56	-	-	-	-
Total Assets, 3 Yr. CAGR %	83.45	1.78	-35.84	-58.01	-8.96
Tangible Book Value, 3 Yr. CAGR %	186.39	82.27	-26.46	-63.01	-17.23
Common Equity, 3 Yr. CAGR %	212.32	-0.62	-37.98	-66.08	-17.23
Cash From Operations, 3 Yr. CAGR %	34.66	14.96	7.6	-23.73	-35.02
Levered Free Cash Flow, 3 Yr. CAGR %	74.65	48.3	0.82	-8.68	-49.75
Unlevered Free Cash Flow, 3 Yr. CAGR %	74.65	48.3	0.82	-8.68	-49.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-6.34	-	-	-	-
Gross Profit, 5 Yr. CAGR %	49.22	124.49	-	-	-
EBITDA, 5 Yr. CAGR %	49.34	67.69	50.52	-7.03	-12.05
EBITA, 5 Yr. CAGR %	49.39	67.46	50.24	-7.05	-12.06
EBIT, 5 Yr. CAGR %	49.35	67.38	50.24	-7.05	-12.06
Earnings From Cont. Operations, 5 Yr. CAGR %	59.84	78.44	49.68	-4.27	11.23
Net Income, 5 Yr. CAGR %	59.84	78.44	49.68	-4.27	11.23
Normalized Net Income, 5 Yr. CAGR %	59.84	67.07	49.68	-4.27	-11.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-33.92	-	-	-	12.37
Total Assets, 5 Yr. CAGR %	103.51	84.25	-0.08	-26.29	-15.01
Tangible Book Value, 5 Yr. CAGR %	92.61	28.48	32.99	-2.49	-15.03
Common Equity, 5 Yr. CAGR %	104.89	29.06	32.99	-32.24	-23.28
Cash From Operations, 5 Yr. CAGR %	205.87	64.6	25.19	-17.13	-14.08
Levered Free Cash Flow, 5 Yr. CAGR %	-	84.5	65.24	-7.64	-26.96
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	84.5	65.24	-7.64	-26.96